-
1
-
-
0000785227
-
Study on the chemical constituents of salvia prionitis
-
Yang BJ, Huang XL, Huang Y, Wang XM, Lin LZ. Study on the chemical constituents of salvia prionitis. Acta Botan Sin 1988; 30: 524-7.
-
(1988)
Acta Botan Sin
, vol.30
, pp. 524-527
-
-
Yang, B.J.1
Huang, X.L.2
Huang, Y.3
Wang, X.M.4
Lin, L.Z.5
-
2
-
-
2142847115
-
A new diterpenoid quinone dehydromiltirone
-
Lin LZ, Wang XM, Huang XL, Huang Y, Yang BJ. A new diterpenoid quinone dehydromiltirone. Acta Pharm Sin 1988; 23: 273-5.
-
(1988)
Acta Pharm Sin
, vol.23
, pp. 273-275
-
-
Lin, L.Z.1
Wang, X.M.2
Huang, X.L.3
Huang, Y.4
Yang, B.J.5
-
3
-
-
0001083674
-
Diterpenoids from salvia prionitis
-
Lin LZ, Wang XM, Huang XL, Huang Y, Yang BJ. Diterpenoids from salvia prionitis. Planta Med 1988; 54: 443-5.
-
(1988)
Planta Med
, vol.54
, pp. 443-445
-
-
Lin, L.Z.1
Wang, X.M.2
Huang, X.L.3
Huang, Y.4
Yang, B.J.5
-
5
-
-
38249026574
-
Salvonitin, a diterpene from Salvia prionitis
-
Lin LZ, Cordell GA. Salvonitin, a diterpene from Salvia prionitis. Phytochemistry 1989; 28: 2846-7.
-
(1989)
Phytochemistry
, vol.28
, pp. 2846-2847
-
-
Lin, L.Z.1
Cordell, G.A.2
-
7
-
-
0001668768
-
Structural elucidation of salpriolactone
-
Huang XL, Wang XM, Huang Y, Zhang JS, Lin LZ. Structural elucidation of salpriolactone. Acta Botan Sin 1990; 32: 490-1.
-
(1990)
Acta Botan Sin
, vol.32
, pp. 490-491
-
-
Huang, X.L.1
Wang, X.M.2
Huang, Y.3
Zhang, J.S.4
Lin, L.Z.5
-
8
-
-
0002598198
-
Two new diterpenoids, prioketolactone and neoprionitone from salvia prionitis
-
Zhang JS, Huang Y. Two new diterpenoids, prioketolactone and neoprionitone from salvia prionitis. Nat Prod Res Develop 1995; 7: 1-4.
-
(1995)
Nat Prod Res Develop
, vol.7
, pp. 1-4
-
-
Zhang, J.S.1
Huang, Y.2
-
9
-
-
84965822602
-
Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay
-
Alley MC, Scudiero DA, Monks A, Hursey ML, Czerwinski MJ, Fine DL, et al. Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res 1988; 48: 589-601.
-
(1988)
Cancer Res
, vol.48
, pp. 589-601
-
-
Alley, M.C.1
Scudiero, D.A.2
Monks, A.3
Hursey, M.L.4
Czerwinski, M.J.5
Fine, D.L.6
-
10
-
-
0021061819
-
Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays
-
Mosmman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 1983; 65: 55-63.
-
(1983)
J Immunol Meth
, vol.65
, pp. 55-63
-
-
Mosmman, T.1
-
11
-
-
0002439504
-
Clinical pharmacology of cancer chemotherapy
-
DeVita VT, Hellman S, Rosenberg SA, editors. Philadelphia: JB Lippincott Co
-
Chabner BA, Myers CE. Clinical pharmacology of cancer chemotherapy. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer principles and practice of oncology. Philadelphia: JB Lippincott Co; 1982. p157, 181.
-
(1982)
Cancer Principles and Practice of Oncology
, pp. 157
-
-
Chabner, B.A.1
Myers, C.E.2
-
12
-
-
0025877991
-
Camptothecin, teniposide, or 4′-(9-acridinylamino)-3-methanesulfon-m-anisidide, but not mitoxantrone or doxombicin, induces degradation of nuclear DNA in the S phase of HL-60 cells
-
Del Bino G, Darzynkiewicz Z. Camptothecin, teniposide, or 4′-(9-acridinylamino)-3-methanesulfon-m-anisidide, but not mitoxantrone or doxombicin, induces degradation of nuclear DNA in the S phase of HL-60 cells. Cancer Res 1991; 51: 1165-9.
-
(1991)
Cancer Res
, vol.51
, pp. 1165-1169
-
-
Del Bino, G.1
Darzynkiewicz, Z.2
-
13
-
-
0025133118
-
Involvement of nucleic acid synthesis in cell killing mechanism of topoisomerase poisons
-
D'Arpa P, Beardmore G, Liu LF. Involvement of nucleic acid synthesis in cell killing mechanism of topoisomerase poisons. Cancer Res 1990; 50: 6919-24.
-
(1990)
Cancer Res
, vol.50
, pp. 6919-6924
-
-
D'Arpa, P.1
Beardmore, G.2
Liu, L.F.3
|